New osteoporosis drug copycat tested in healthy volunteers
Disease control
ENROLLING_BY_INVITATION
This early-stage study tests whether a new drug called SAL023 works the same as the approved drug Evenity for osteoporosis. It involves 118 healthy Chinese adults aged 18-45. The main goal is to compare how the body processes each drug and to check for side effects. This is not a…
Phase: PHASE1 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC